跳至主要内容
临床试验/CTRI/2023/07/054891
CTRI/2023/07/054891尚未招募Unknown

To compare the effect of Atorvastatin & Atorvastatin plus Ezetimibe on lipid profile in chronic kidney disease patients : A Randomised control trial - Nil

Dr Dolly Narwal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Who gives consent.
  • 2. Patients with Chronic Kidney Disease between Age group of 40-60 years.
  • 3. On Conservative Management for Chronic Kidney Disease.
  • 4. As evidenced radiologically (Bilateral Shruken Kidney /Loss of corticomedullary differentiation) or biochemically (elevated blood urea, serum creatinine) for more than 3 months.
  • 5. With known Chronic Kidney Disease irrespective of the etiology.

排除标准

  • 1. Patients with Acute renal failure and Nephrotic syndrome.
  • 2. Patients on drugs affecting Lipid metabolism like Beta Blockers, steroids and Oral contraceptive pills.
  • 3. Female patients who are pregnant.
  • 4. Known Hypothyroidism patients.

研究者

发起方
Dr Dolly Narwal

相似试验